Building toward the clinic: navigating the transition from GLP to GMP

Moving from promising preclinical data to a clinically viable candidate is where many programs struggle.

Join us for a session on preparing for GMP readiness and building the quality systems needed to support clinical development. We will discuss the transition from lab-scale research to process development, including the analytical testing and manufacturing considerations that emerge along the way.

If you are thinking about commercialization and want a clearer understanding of what it takes to move a drug candidate toward the clinic, we invite you to join the discussion.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Joice Kanefsky